The Determination of the Plaque Burden on the Carotid Artery With Ultrasound Significantly Improves the Risk Prediction in Middle-Aged Subjects Compared to PROCAM: An Outcome Study.

Cardiovascular risk Carotid ultrasound Coronary disease Total plaque area

Journal

Cardiology research
ISSN: 1923-2829
Titre abrégé: Cardiol Res
Pays: Canada
ID NLM: 101557543

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 15 04 2020
accepted: 24 04 2020
entrez: 30 6 2020
pubmed: 1 7 2020
medline: 1 7 2020
Statut: ppublish

Résumé

There are only few data about the predictive value of atherosclerosis imaging beyond traditional risk calculators in younger subjects. We assessed cardiovascular risk prediction with the PROCAM (the Prospective Cardiovascular Munster Study) risk equation and with carotid plaque imaging (determination of total plaque area (TPA) and the maximum plaque thickness with ultrasound) in subjects without known cardiovascular diseases. The follow-up was generated during follow-up examinations as part of preventive medical examinations or by telephone calls. In 2,508 subjects aged 35 - 64 years (50 ± 8 years, 34% women), 132 (5.3%) cardiovascular events occurred (42 myocardial infarction, 17 bypass surgery, 31 stent implantation, 42 coronary artery disease defined by invasive angiography) during a mean follow-up period of 5.4 (1 - 12) years. TPA in combination with the maximum plaque thickness (type III - IV b plaques ) tended to be superior compared to TPA, and both plaque imaging methods were superior to PROCAM: area under the curve (AUC) 0.9 (95% confidence interval (CI): 0.91 - 0.89) vs. 0.89 (95% CI: 0.90 - 0.88), P = 0.2 vs. 0.82 (95% CI: 0.84 - 0.81), P = 0.001; positive predictive value (PPV) 27% (95% CI: 0.31 - 0.22) vs. 19% (95% CI: 0.22 - 0.16) vs.19% (95% CI: 0.27 - 0.13). Amount of carotid plaque assessed by carotid plaque imaging significantly improves cardiovascular risk prediction beyond the PROCAM risk equation.

Sections du résumé

BACKGROUND BACKGROUND
There are only few data about the predictive value of atherosclerosis imaging beyond traditional risk calculators in younger subjects.
METHODS METHODS
We assessed cardiovascular risk prediction with the PROCAM (the Prospective Cardiovascular Munster Study) risk equation and with carotid plaque imaging (determination of total plaque area (TPA) and the maximum plaque thickness with ultrasound) in subjects without known cardiovascular diseases. The follow-up was generated during follow-up examinations as part of preventive medical examinations or by telephone calls.
RESULTS RESULTS
In 2,508 subjects aged 35 - 64 years (50 ± 8 years, 34% women), 132 (5.3%) cardiovascular events occurred (42 myocardial infarction, 17 bypass surgery, 31 stent implantation, 42 coronary artery disease defined by invasive angiography) during a mean follow-up period of 5.4 (1 - 12) years. TPA in combination with the maximum plaque thickness (type III - IV b plaques ) tended to be superior compared to TPA, and both plaque imaging methods were superior to PROCAM: area under the curve (AUC) 0.9 (95% confidence interval (CI): 0.91 - 0.89) vs. 0.89 (95% CI: 0.90 - 0.88), P = 0.2 vs. 0.82 (95% CI: 0.84 - 0.81), P = 0.001; positive predictive value (PPV) 27% (95% CI: 0.31 - 0.22) vs. 19% (95% CI: 0.22 - 0.16) vs.19% (95% CI: 0.27 - 0.13).
CONCLUSIONS CONCLUSIONS
Amount of carotid plaque assessed by carotid plaque imaging significantly improves cardiovascular risk prediction beyond the PROCAM risk equation.

Identifiants

pubmed: 32595808
doi: 10.14740/cr1067
pmc: PMC7295556
doi:

Types de publication

Journal Article

Langues

eng

Pagination

233-238

Informations de copyright

Copyright 2020, Adams et al.

Déclaration de conflit d'intérêts

The authors declare that there is no conflict of interest.

Références

Stroke. 2002 Dec;33(12):2916-22
pubmed: 12468791
Eur Heart J. 2016 Aug 1;37(29):2315-2381
pubmed: 27222591
Echocardiography. 2016 Feb;33(2):281-9
pubmed: 26122814
Dtsch Arztebl Int. 2012 May;109(21):385-90
pubmed: 22690254
JAMA. 2014 Nov 5;312(17):1754-63
pubmed: 25369489
Stroke. 2007 Nov;38(11):2873-80
pubmed: 17901390
Atherosclerosis. 2012 Jan;220(1):128-33
pubmed: 21764060
J Am Heart Assoc. 2013 Apr 18;2(2):e000180
pubmed: 23598274
N Engl J Med. 2011 Jan 20;364(3):226-35
pubmed: 21247313
Eur Heart J. 2020 Jan 1;41(1):111-188
pubmed: 31504418
Arterioscler Thromb Vasc Biol. 2006 Mar;26(3):656-62
pubmed: 16357319
J Am Heart Assoc. 2013 Apr 08;2(2):e000087
pubmed: 23568342
Curr Cardiol Rep. 2009 Jan;11(1):21-7
pubmed: 19091171
J Am Coll Cardiol. 2010 Apr 13;55(15):1600-7
pubmed: 20378078
Neurology. 2008 Apr 1;70(14):1200-7
pubmed: 18354078
Cardiol Res. 2016 Feb;7(1):9-16
pubmed: 28197263
Atherosclerosis. 2001 Jun;156(2):379-87
pubmed: 11395035
Eur J Clin Invest. 2007 Dec;37(12):925-32
pubmed: 18036028
Circulation. 1980 Oct;62(4):712-7
pubmed: 7408144
Dtsch Arztebl Int. 2009 Jun;106(24):403-6
pubmed: 19623307
Cardiol Res. 2018 Feb;9(1):22-27
pubmed: 29479382
J Am Coll Cardiol. 2015 Mar 24;65(11):1065-74
pubmed: 25790876
Herz. 2015 Aug;40(5):817-22
pubmed: 25997426
Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):981-9
pubmed: 25676000
Stroke. 2011 Apr;42(4):972-8
pubmed: 21311059
Int Angiol. 2010 Jun;29(3):216-25
pubmed: 20502408

Auteurs

Ansgar Adams (A)

B·A·D Gesundheitsvorsorge und Sicherheitstechnik GmbH Zentrum Koblenz, Koblenz, Germany.

Waldemar Bojara (W)

Medizinische Klinik Kardiologie Koblenz, Gemeinschaftsklinikum Kemperhof II, Koblenz, Germany.

Michel Romanens (M)

Vascular Risk Foundation (Varifo), Olten, Switzerland.

Classifications MeSH